Sun Pharma, Ranbaxy Hit 52-Week Highs on Merger Nod

Share of Sun Pharmaceutical Industries and Ranbaxy Laboratories traded at 52-week highs after Sun Pharma received US Federal Trade Commission (FTC) clearance for Ranbaxy's acquisition.